These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 38603857)

  • 1. Semaphorins in tumor microenvironment: Biological mechanisms and therapeutic progress.
    Chen T; Li S; Wang L
    Int Immunopharmacol; 2024 May; 132():112035. PubMed ID: 38603857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of semaphorins and their receptors in vascular development and cancer.
    Gu C; Giraudo E
    Exp Cell Res; 2013 May; 319(9):1306-16. PubMed ID: 23422037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semaphorin signals tweaking the tumor microenvironment.
    Muratori C; Tamagnone L
    Adv Cancer Res; 2012; 114():59-85. PubMed ID: 22588056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semaphorins at the interface of development and cancer.
    Flannery E; Duman-Scheel M
    Curr Drug Targets; 2009 Jul; 10(7):611-9. PubMed ID: 19601765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune semaphorins: Crucial regulatory signals and novel therapeutic targets in asthma and allergic diseases.
    Kalmarzi RN; Rajabinejad M; Lotfi R
    Eur J Pharmacol; 2020 Aug; 881():173209. PubMed ID: 32454117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The semaphorins and their receptors as modulators of tumor progression.
    Neufeld G; Mumblat Y; Smolkin T; Toledano S; Nir-Zvi I; Ziv K; Kessler O
    Drug Resist Updat; 2016 Nov; 29():1-12. PubMed ID: 27912840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Semaphorins and tumor angiogenesis.
    Serini G; Maione F; Giraudo E; Bussolino F
    Angiogenesis; 2009; 12(2):187-93. PubMed ID: 19266292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging roles and mechanisms of semaphorins activity in cancer.
    Bica C; Tirpe A; Nutu A; Ciocan C; Chira S; Gurzau ES; Braicu C; Berindan-Neagoe I
    Life Sci; 2023 Apr; 318():121499. PubMed ID: 36775114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semaphorins as emerging clinical biomarkers and therapeutic targets in cancer.
    Mastrantonio R; You H; Tamagnone L
    Theranostics; 2021; 11(7):3262-3277. PubMed ID: 33537086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semaphorin signaling in cancer cells and in cells of the tumor microenvironment--two sides of a coin.
    Capparuccia L; Tamagnone L
    J Cell Sci; 2009 Jun; 122(Pt 11):1723-36. PubMed ID: 19461072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of semaphorins in cardiovascular diseases: Potential therapeutic targets and novel biomarkers.
    Yin Z; Zhang J; Xu S; Liu J; Xu Y; Yu J; Zhao M; Pan W; Wang M; Wan J
    FASEB J; 2022 Oct; 36(10):e22509. PubMed ID: 36063107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the semaphorins in cancer.
    Neufeld G; Mumblat Y; Smolkin T; Toledano S; Nir-Zvi I; Ziv K; Kessler O
    Cell Adh Migr; 2016 Nov; 10(6):652-674. PubMed ID: 27533782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of immune semaphorins in the pathogenesis of multiple sclerosis: Potential therapeutic targets.
    Lotfi R; Nasiri Kalmarzi R; Rajabinejad M; Hasani S; Zamani F
    Int Immunopharmacol; 2021 Jun; 95():107556. PubMed ID: 33756227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Semaphorins in angiogenesis and tumor progression.
    Neufeld G; Sabag AD; Rabinovicz N; Kessler O
    Cold Spring Harb Perspect Med; 2012 Jan; 2(1):a006718. PubMed ID: 22315716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pan-cancer study of class-3 semaphorins as therapeutic targets in cancer.
    Zhang X; Klamer B; Li J; Fernandez S; Li L
    BMC Med Genomics; 2020 Apr; 13(Suppl 5):45. PubMed ID: 32241267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential of class 3 semaphorins as both targets and therapeutics in cancer.
    Mishra R; Kumar D; Tomar D; Chakraborty G; Kumar S; Kundu GC
    Expert Opin Ther Targets; 2015 Mar; 19(3):427-42. PubMed ID: 25434284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Semaphorins in cancer.
    Neufeld G; Shraga-Heled N; Lange T; Guttmann-Raviv N; Herzog Y; Kessler O
    Front Biosci; 2005 Jan; 10():751-60. PubMed ID: 15569615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropilins: novel targets for anti-angiogenesis therapies.
    Geretti E; Klagsbrun M
    Cell Adh Migr; 2007; 1(2):56-61. PubMed ID: 19329879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression patterns and pathogenesis of Semaphorin class 4 subfamily proteins in solid tumors.
    Jiang D; Chen X; Li X; Qiu J; Xu P; Li X
    Neoplasma; 2024 Feb; 71(1):1-12. PubMed ID: 38295103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semaphorins in cancer: biological mechanisms and therapeutic approaches.
    Rehman M; Tamagnone L
    Semin Cell Dev Biol; 2013 Mar; 24(3):179-89. PubMed ID: 23099250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.